1. Home
  2. ADV vs MASS Comparison

ADV vs MASS Comparison

Compare ADV & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advantage Solutions Inc.

ADV

Advantage Solutions Inc.

HOLD

Current Price

$28.86

Market Cap

209.6M

ML Signal

HOLD

Logo 908 Devices Inc.

MASS

908 Devices Inc.

HOLD

Current Price

$7.36

Market Cap

228.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADV
MASS
Founded
1987
2012
Country
United States
United States
Employees
69000
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
209.6M
228.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ADV
MASS
Price
$28.86
$7.36
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$45.83
$12.00
AVG Volume (30 Days)
472.2K
251.7K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.47
EPS
N/A
0.54
Revenue
N/A
$56,197,000.00
Revenue This Year
$0.63
$19.44
Revenue Next Year
$0.45
$18.63
P/E Ratio
N/A
$13.56
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$4.20
52 Week High
$30.00
$9.34

Technical Indicators

Market Signals
Indicator
ADV
MASS
Relative Strength Index (RSI) 77.91 68.07
Support Level $1.00 $5.86
Resistance Level N/A $7.42
Average True Range (ATR) 3.00 0.33
MACD 0.86 0.12
Stochastic Oscillator 95.48 81.68

Price Performance

Historical Comparison
ADV
MASS

About ADV Advantage Solutions Inc.

Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.

About MASS 908 Devices Inc.

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

Share on Social Networks: